Subsidizing Charitable Giving with Rebates or Matching: Further Laboratory Evidence

We examine two different ways to subsidize charitable giving: by a rebate (returning a portion of the donation to the giver) or by a match (adding additional donations to the giver's donation). In previous experimental research, we have shown that participants give more to charity under the match than under an equivalent rebate. The previous within-subject experimental design required participants to make a series of decisions under both types of subsidy. Each decision consisted of an allocation of an endowment between the subject and a charity chosen by the subject from a specified list. This article examines whether that result is an artifact of the previous within-subjects design: subjects may have failed to fully distinguish the two types of subsidy. In the current article, we report results from a between-subjects design, where participants are required to make only one type of decision—involving rebates or involving matching subsidies. Our results confirm previous findings.     

Risk analysis of new maize technology in Zaire: a portfolio approach

Risk associated with the adoption of new maize technology and the impact of mandatory cotton production on traditional farmers in the Kasai Oriental Region of Zaire are evaluated within a portfolio context using a quadratic programming model. Seasonal net returns for farm plans including four levels of maize technology in combination with staple food crops are evaluated, with and without mandatory cotton production. The results indicate that cropping systems that include new maize technology are risk-efficient relative to local maize varieties while mandatory cotton production is not risk-efficient at the prevalent price and yield levels in the farming system.     

Third world strategies for regulating drug advertising and marketing

In the pharmaceutical area, third world countries have been particularly subjected to excessive pricing and manipulative marketing practices by multinational corporations. Sri Lanka has gained some experience in curbing abuses by establishing a State Pharmaceuticals Corporation. It has been able to achieve substantial price cuts for pharmaceuticals and to adapt to changing economic and political circumstances. The control of advertising and marketing practices remains a problem but has been tackled in Sri Lanka by an Act of 1980. Until similar laws are enacted greater attention should be given to the individual patient by doctors becoming more circumspect in prescribing drugs.

---

Strategien der Länder der Dritten Welt zur Regulierung des Vertriebs und der Werbung von Arzneimitteln

Zusammenfassung Länder der Dritten Welt sind für multinationale Unternehmen auf dem Arzneimittelsektor ein bevorzugtes Objekt für Ausbeutung durch überhöhte Preise oder manipulatives Marketing. Der Autor, mit diesen Problemen an leitender Stelle persönlich vertraut, beschreibt Versuche in Sri Lanka, Mißbräuche ausländischer Unternehmen durch Errichtung einer staatlichen pharmazeutischen Gesellschaft (State Pharmaceuticals Corporation) zu bekämpfen.Das Unternehmen hat wesentliche Preisreduzierungen für Arzneimittel erreicht und sich an geänderte wirtschaftliche und politische Verhältnisse anpassen können. Werbung und Vertriebsmethoden werden neuerdings in Sri Lanka — wie in anderen Ländern der Dritten Welt — durch ein Gesetz von 1980 kontrolliert, das allerdings für homöopathische und ähnliche Produkte nicht gilt. In der Zukunft kommt es darauf an, den individuellen Patienten durch eine vorsichtigere Verschreibung von Arzneimitteln mehr Aufmerksamkeit zu widmen.

---

---

D. C. Jayasuriya is Attorney-at-Law and Senior State Counsel. His address is 40/12, Swarnadisi Place off Koswatte Road, Nawala, Sri Lanka.